Key points:
- CVS reported first quarter earnings before the open
- The company beat earnings and revenue expectations
- It also raised full-year earnings guidance
- CVS Shares Fall Despite Earnings, Revenue Beat
CVS Health Corporation (NYSE: CVS)reported first-quarter earnings before the open Wednesday, beating analyst estimates.
The company announced adjusted earnings per share of $2.22, with revenue coming in at $76.83 billion.
The numbers reported were against an anticipated EPS of $2.15 and revenue of $75.39 billion.
WELCOME BONUS - Free Share Bundle When You Invest £50!
Open a UK Investment Account: Shares, ISAs, Managed Portfolio
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
IG
View Offers
Empfohlener Broker
Multi Asset Platform
Also Read: What Do Quarterly Earnings Mean for Investors?
In reaction to the report, CVS’s share price has moved 1.8% higher to $97.71.
The company also raised its guidance for the full year, expecting adjusted earnings per share between $8.20 to $8.40 from the previous $8.10 to $8.30.
“Our strategy improves access to affordable, convenient and personalized health care, which benefits consumers and shareholders. We once again showed the power of our purpose and potential, building on our strong momentum and raising full-year guidance as a result,” said Karen Lynch, CVS Health President, and CEO.